首都医科大学学报 ›› 2008, Vol. 29 ›› Issue (2): 227-229.

• 临床研究 • 上一篇    下一篇

慢性乙型重型肝炎低血糖患者IGF-1水平及其意义

张汾燕, 于红卫, 孟庆华, 段忠辉, 冯岩梅   

  1. 首都医科大学附属北京佑安医院肝病四科
  • 收稿日期:2007-07-04 修回日期:1900-01-01 出版日期:2008-04-24 发布日期:2008-04-24
  • 通讯作者: 孟庆华

Detection and Clinical Significance of the Serum Free Insulin-like Growth Factor 1 in Patients with Chronic Severe Hepatitis B and Hypoglycemia

Zhang Fenyan, Yu Hongwei, Meng Qinghua, Duan Zhonghui, Feng Yanmei   

  1. Department of the 4th Hepatology, Beijing You'an Hospital, Capital Medical University
  • Received:2007-07-04 Revised:1900-01-01 Online:2008-04-24 Published:2008-04-24

摘要: 目的 探讨慢性乙型重型肝炎(简称慢重肝)低血糖患者血清胰岛素样生长因子-1(IGF-1)水平及其与空腹血糖(FBG)、空腹胰岛素(INS)、总胆红素(TBiL)、白蛋白(ALB)、凝血酶原活动度(PTA)和呼吸商(RQ)的关系.方法 以20例慢重肝低血糖患者为研究对象,20例慢性乙型肝炎(慢肝)患者为对照组,用免疫放射法测定比较2组患者血清IGF-1及INS水平,采用间接测热法应用CCM D营养代谢测试系统检测2组患者的呼吸商,探讨其与IGF-1水平的关系.结果 慢重肝组血清IGF-1水平(11.9±2.6)μg/L明显低于慢肝组(159.8±35.7)μg/L(P<0.01);慢重肝组中晚期IGF-1水平为(8.99±4.61)μg/L,病死率为60%,早期IGF-1水平为(15.43±3.70)μg/L,病死率为20%,2组间中晚期、早期IGF-1水平及病死率差异有统计学意义(P<0.01);慢重肝组INS水平(19.2±10.9)mIU/L明显高于慢肝组(10.6±7.3)mIU/L(P<0.05);慢重肝患者IGF 1<19.03 μg/L,提示预后不佳;慢重肝组血清IGF 1水平与ALB、PTA、RQ正相关性(B=0.O45、B=0.O32、B=0.O65,P均<0.05),与INS负相关(B=-0.053,P<0.05),与TBiL、FBG无相关性(B=0.32、B=0.78,P均>0.05).结论 慢重肝患者血清IGF-1水平显著下降,且与病情严重程度有关,提示IGF-1是反映慢重肝患者预后指标之一,且与低血糖发生密切相关.

关键词: 慢性重型肝炎, 胰岛素样生长因子-1, 呼吸商

Abstract: Objective To investigate the changes in serum insulin-like growth factor 1(IGF-1) in patients with chronic severe hepatitis B and hypoglycemia and its relationship to the fasting blood glucose and serum insulin, liver functions and respiratory quotient(RQ). Methods Twenty patients with severe chronic hepatitis B and hypoglycemia and 20 patients with chronic hepatitis B only as the control were recruited. The levels of serum insulin-like growth factor(IGF-1) and the fasting insulin were detected with RIA in the two groups, and the differences were compared; indirect calorimetry was employed to detect RQ. Results The levels of serum IGF-1(11.9±2.6)μg/L in patients with severe chronic hepatitis B and hypoglycemia were significantly lower than those in patients with chronic hepatitis B and (159.8±35.7)μg/L(P<0.01); The levels of serum IGF-1 in patients with intermediate and advanced stages of severe chronic hepatitis B were(8.99±4.61)μg/L; case fatality was 60%, The levels of serum IGF-1 in patients with morning stage severe chronic hepatitis B were(15.43±3.70)μg/L and case fatality was 20%. The levels of serum insulin with severe chronic hepatitis B(19.2±10.9)mIU/L were significantly higher than those in patients with chronic hepatitis B only(10.6±7.3)mIU/L(P<0.01). The differences in the levels of serum IGF-1 and case fatality between intermediate and advanced stages and morning stage were significant(P<0.01). When the level of serum IGF-1 in patients with severe chronic hepatitis B was lower than 19.03 μg/L. It suggested poor prognosis. The level of IGF-1 in patients with severe chronic hepatitis B and hypoglycemia had positive correlation with the ALB, PTA and RQ(B=0.O45, B=0.O32, B=0.O65 respectively, P<0.05), and negative correlation with the fasting serum insulin(B=-0.053, P<0.05). However it had no correlation with TBIL and the fasting blood glucose(B=0.32, B=0.78 respectively, P>0.05). Conclusion The level of serum IGF-1 is significantly decreased in patients with severe chronic hepatitis B, and is closely correlated with the severity of the disease, which suggests that IGF-1 might be an indicator of prognosis in patients with severe chronic hepatitis B and has close relationship with the development of hypoglycemia.

Key words: severe chronic hepatitis B, insulin-like growth factor 1, respiratory quotient

中图分类号: